As the presidential candidates’ positions on cannabis policy make the headlines, it’s important to remember that the real power to shape cannabis laws doesn’t reside in the Oval Office.
Over the years, advocates have fought for patients’ rights to access medical cannabis under numerous presidencies. Yet, the biggest strides in protecting medical cannabis patients haven’t come from the White House — they’ve come from Congress.
Yes, the president can sign legislation, influence federal agencies and set policy priorities. Both Kamala Harris and Donald Trump have expressed support for moving cannabis to Schedule III and even hinted at legalization.
But here’s the reality: Neither has the authority to make these changes. Even the rescheduling process is out of their influence, in the hands of a Drug Enforcement Agency that is resisting the move to Schedule III.
Read the full article at The Hill
